Annual Report 2025

3 The United Laboratories International Holdings Limited Annual Report 2025 • The United Laboratories was recognized at the 7th China Medicine Connect Expo (CMC-CHINA 2025) as one of the “TOP30 2025 China API Business” and “TOP101 2025 China Pharmaceutical Industry”. • 聯邦 ® 阿莫仙 ® were named to the “2025 Healthy China Brand List” and awarded the CPEO Gold Award. AUGUST • UBT37034 Injection, a Class 1 innovative drug, has been approved for phase I clinical trial in China on indications of overweight or obesity. • In partnership with JD Health, The United Laboratories launched 聯邦優利泰 ® (Liraglutide Injection) exclusively across its full online platform. • The Ampicillin Sodium aseptic API of Zhuhai United Laboratories Co., Ltd. received the CEP certificate issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM). • The United Laboratories won the “Best ESG Pioneer Practice Listed Company Award” from the “Golden Kunpeng” China Financial Value Ranking. SEPTEMBER • Zhuhai United Laboratories Co., Ltd. ranked 61st in the “Top 500 Manufacturing Enterprises in Guangdong Province for 2025”. OCTOBER • United Animal Healthcare launched seven products, including Cefovecin Sodium for Injection, covering anti-infectives, chronic disease management, skin health, nutritional support and environmental disinfection for pets. • The United Laboratories participated in the 27th Academic Conference of the Chinese Diabetes Society. • The United Laboratories ranked 10th on the “2025 China Innovative Drug Global Expansion Leading Enterprises Top 40”. • The United Laboratories received the “2025 Top20 Most Competitive Chinese Pharmaceutical Listed Companies” and “2025 Top20 ESG Competitiveness among Chinese Pharmaceutical Listed Companies” awarded by Healthcare Executive. NOVEMBER • Moxifloxacin Hydrochloride Eye Drops (specifications: 0.5% (3ml: 15mg), 0.5% (5ml: 25mg)) and Levofloxacin Eye Drops (specification: 0.488% (5ml: 24.4mg)) of The United Laboratories have been approved by NMPA. • The United Laboratories was honored with the “Enterprise with Excellent Influence in ESG” by Hong Kong Commercial Daily. DECEMBER CORPORATE CALENDAR OF 2025